Accera's Alzheimer's trial fails, in yet another setback for disease - Times of India

MedCity News

Accera's Alzheimer's trial fails, in yet another setback for disease Times of India By Natalie Grover. Feb 28 (Reuters) - Nestle SA-backed Accera Inc said on Tuesday its experimental Alzheimer's drug failed a late-stage study, adding to the laundry list of disappointments in the pursuit of an effective treatment for the rampant mind ... More Phase 3 disappointment in Alzheimer's diseaseMedCity News Accera Announces Results of its First Phase 3 Study in Mild-to-Moderate Alzheimer's DiseasePR Newswire (press release) all 3 news articles »

from Health - Google News http://ift.tt/2mAlvIp